Skip to main content
. 2019 May 29;9:8028. doi: 10.1038/s41598-019-44361-6

Figure 7.

Figure 7

Treatment with CM from activated fibroblasts increased proliferation and invasion of FTC-133 cells. (A) Schematic representation of CM preparation from MRC-5 cells and treatment of FTC-133 cells. Cell proliferation (B) and in vitro invasion assays (C) were performed in FTC-133 cells incubated with CM derived from activated MRC-5 cells, as described in the Materials and Methods section. Data are expressed as mean ± SD of 3 independent experiments (n = 3) with quadruplicate samples for each experimental group. (D) Immunoblot analysis of vimentin, E-cadherin and GAPDH as a loading control after treatment with CM derived from activated MRC-5 cells. The figure shows representative Western Blots of 3 independent experiments (n = 3) with duplicate samples for each experimental group. (E) Quantification of relative expression of proteins associated with EMT in FTC-133 after using GAPDH as loading control (Full blots are shown in the Supplemental Information, Full Original Blots-VII). Data are expressed as mean ± SD.*p < 0.05 and **p < 0.01.